The product is a human anti-C2 antibody hexamer with enhanced complement-dependent cytotoxicity (CDC) activity. This IgG1 hexamer targets human complement C2 and includes mutations that enhance hexamerization. These specific mutations promote hexamer formation, facilitating optimal C1q binding and boosting CDC efficacy.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-1331CL | Mouse Anti-C2 Recombinant Antibody (TAB-1331CL) | CDC | Mouse IgG1, κ |
TAB-1332CL | Mouse Anti-C2 Recombinant Antibody (TAB-1332CL) | Inhib, CDC, WB | Mouse IgG1, κ |
TAB-1333CL | Mouse Anti-C2 Recombinant Antibody (TAB-1333CL) | Inhib, CDC, WB, FuncS | Mouse IgG1, κ |
TAB-1334CL | Mouse Anti-C2 Recombinant Antibody (TAB-1334CL) | Inhib, CDC, WB | Mouse IgG1, κ |
TAB-1335CL | Mouse Anti-C2 Recombinant Antibody (TAB-1335CL) | CDC | Mouse IgG1, κ |
There are currently no Customer reviews or questions for VS-0924-YC101. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.